2019 Vol. 10, No. 5

Diagnosis and Treatment Specifications
Technical specification for operation of renal transplantation (2019 edition):indications, contraindications, preoperative examination and preparation
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 469-472, 482. doi: 10.3969/j.issn.1674-7445.2019.05.001
Abstract(1063) HTML (339) PDF 815KB($!{article.pdfDownCount})
Abstract:
Technical operation specification for perfusion, preservation and repair of donor kidney (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 473-477. doi: 10.3969/j.issn.1674-7445.2019.05.002
Abstract(497) HTML (294) PDF 918KB($!{article.pdfDownCount})
Abstract:
Operation specification for selection and evaluation of deceased donors of renal transplantation (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 478-482. doi: 10.3969/j.issn.1674-7445.2019.05.003
Abstract(323) HTML (169) PDF 825KB($!{article.pdfDownCount})
Abstract:
Technical operation specification for operation of renal transplantation (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 483-488, 504. doi: 10.3969/j.issn.1674-7445.2019.05.004
Abstract(850) HTML (272) PDF 1140KB($!{article.pdfDownCount})
Abstract:
Operation specification for perioperative management of renal transplantation (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 489-493. doi: 10.3969/j.issn.1674-7445.2019.05.005
Abstract(532) HTML (143) PDF 822KB($!{article.pdfDownCount})
Abstract:
Operation specification for function maintenance, evaluation and application of donor kidney in children (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 494-498. doi: 10.3969/j.issn.1674-7445.2019.05.006
Abstract(385) HTML (71) PDF 774KB($!{article.pdfDownCount})
Abstract:
Technical operation specification for renal transplantation in children (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 499-504. doi: 10.3969/j.issn.1674-7445.2019.05.007
Abstract(260) HTML (77) PDF 943KB($!{article.pdfDownCount})
Abstract:
Technical specification for the diagnosis and treatment on rejection of renal transplantation (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 505-512. doi: 10.3969/j.issn.1674-7445.2019.05.008
Abstract(1278) HTML (777) PDF 882KB($!{article.pdfDownCount})
Abstract:
Technical operation specification for tissue matching and immune monitoring techniques in renal transplantation (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 513-520. doi: 10.3969/j.issn.1674-7445.2019.05.009
Abstract(424) HTML (353) PDF 962KB($!{article.pdfDownCount})
Abstract:
Technical specification for the diagnosis and treatment on delayed graft function after renal transplantation (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 521-525. doi: 10.3969/j.issn.1674-7445.2019.05.010
Abstract(963) HTML (604) PDF 825KB($!{article.pdfDownCount})
Abstract:
Technical specification for diagnosis and treatment of chronic renal allograft dysfunction (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 526-532, 539. doi: 10.3969/j.issn.1674-7445.2019.05.011
Abstract(479) HTML (154) PDF 4681KB($!{article.pdfDownCount})
Abstract:
Technical operation specification for ABO-incompatible kidney transplantation from relative living donor (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 533-539. doi: 10.3969/j.issn.1674-7445.2019.05.012
Abstract(661) HTML (223) PDF 842KB($!{article.pdfDownCount})
Abstract:
Clinical technical operation specification for living donor kidney transplantation (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 540-546. doi: 10.3969/j.issn.1674-7445.2019.05.013
Abstract(369) HTML (146) PDF 840KB($!{article.pdfDownCount})
Abstract:
Technical operation specification for renal retransplantation (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 547-551. doi: 10.3969/j.issn.1674-7445.2019.05.014
Abstract(258) HTML (223) PDF 858KB($!{article.pdfDownCount})
Abstract:
Clinical operation specification for small intestine allograft pathology (2019 edition)
Branch of Organ Transplantation of Chinese Medical Association
2019, 10(5): 552-558. doi: 10.3969/j.issn.1674-7445.2019.05.015
Abstract(217) HTML (68) PDF 2218KB($!{article.pdfDownCount})
Abstract:
Editorial
Mineral and bone abnormalities after renal transplantation
Li Ning
2019, 10(5): 559-569. doi: 10.3969/j.issn.1674-7445.2019.05.016
Abstract(231) HTML (148) PDF 903KB($!{article.pdfDownCount})
Abstract:
Clinical Researches
Sofosbuvir-based regimens combined with ribavirin for recipients with genotype 1 hepatitis C after liver transplantation: a Meta-analysis
Jiang Xiao, Jiang Xiaojuan, Su Ruiliang, Ren Zhijian, Yang Jinwei, Li Yumin
2019, 10(5): 570-577. doi: 10.3969/j.issn.1674-7445.2019.05.017
Abstract(157) HTML (84) PDF 2427KB($!{article.pdfDownCount})
Abstract:
  Objective  To evaluate whether sofosbuvir (SOF)-based direct-acting antiviral agents (DAAs) combined with ribavirin (RBV) (combined RBV) can yield benefits to the recipients infected with hepatitis C virus (HCV) genotype 1 (GT1) after liver transplantation through systematic evaluation and Meta-analysis.  Methods  Multiple databases at home and abroad were systematically searched, the literature screening was conducted according to relevant standards, the quality of literatures was evaluated and data extraction was performed. The literature was divided into two groups according to the recipients with HCV-GT1 hepatitis after liver transplantation who received the treatment combined RBV or SOF-based DAAs alone without RBV (not combined RBV). Meta-analysis of the data was carried out using Rev Man 5.3 and R3.4.3 software. The incidence of sustained virological response 12 weeks (SVR12) after therapy was evaluated.  Results  A total of 2 195 articles were retrieved, and 6 articles published in English were eventually included according to the inclusion criteria. The Meta-analysis results demonstrated that the incidence of SVR12 did not significantly differ between the combined RBV and not combined RBV groups (P=0.28). However, the incidence of anemia in the combined RBV group was significantly higher than that in the other group (P < 0.01). Both combined RBV and not combined RBV therapies were efficacious in treating HCV-GT1a and HCV-GT1b subtypes after liver transplantation with similar clinical efficacy (P=0.33). The incidence of SVR in HCV-GT1 recipients did not significantly differ after receiving 12- and 24-weeks therapy after liver transplantation (P=0.95).  Conclusions  When SOF-based DAAs regimen is adopted to treat HCV-GT1 in recipients after liver transplantation, combination with RBV not only fails to improve the virus clearance rate and bring clinical benefits, but also increases the risk of anemia in the recipients.
Application of retrobulbar nerve block combined with general anesthesia in corneal transplantation
Lai Aihua, Zhang Huang, You Shan, Sun Tao, Liu Xian, Zhou Wentian
2019, 10(5): 578-583. doi: 10.3969/j.issn.1674-7445.2019.05.018
Abstract(218) HTML (124) PDF 1256KB($!{article.pdfDownCount})
Abstract:
  Objective  To explore the application value of retrobulbar nerve block combined with general anesthesia in the penetrating keratoplasty (PKP).  Methods  A total of 100 recipients undergoing PKP from January 2017 to January 2019 were recruited in this study. All recipients were divided into the observation group (n=50) and control group (n=50) by random number table method. In the control group, patients received laryngeal mask airway under general anesthesia, and in the observation group, patients received laryngeal mask airway under general anesthesia combined with retrobulbar nerve block. Hemodynamic changes of the PKP recipients before and after operation were observed in two groups. The dosage of analgesic drugs and the incidence of complications were observed in two groups. The degree of pain at postoperative 2-, 6- and 24-h was evaluated by visual analogue scale (VAS) in two groups. The awakening situation of the recipients in two groups was observed. The levels of inflammatory cytokines at 1 d before and after operation were statistically compared in two groups.  Results  The average arterial pressure and heart rate at intraoperative 15 min and after the surgery in the observation group were significantly higher than those in the control group (both P < 0.05). In the observation group, the dosage of remifentanil and propofol were (1.0±0.4) mg and (299±40) mg, significantly lower than (1.3±0.6) mg and (365±42) mg in the control group (both P < 0.05). The incidence of complications did not significantly differ between two groups (P > 0.05). In the observation group, the VAS scores at 2-, 6- and 12-h after operation were remarkably lower than those in the control group (all P < 0.01). The respiratory recovery time, eye opening time, directional force recovery time and extubation time of the recipients in the observation group were significantly shorter than those in the control group (all P < 0.05). The expression levels of including interleukin (IL)-1, IL-6 and tumor necrosis factor-α (TNF-α) at postoperative 1 d in the observation group were considerably lower than those in the control group (all P < 0.05).  Conclusions  Retrobulbar nerve block combined with general anesthesia can maintain hemodynamic stability during PKP, reduce the dosage of remifentanil and propofol and alleviate the degree of postoperative pain and inflammatory responses of the recipients.
Analysis of the management and clinical effect of accessory renal artery in the living-related donor renal, transplantation
Pan Guozheng, Zhai Fengxian, Li Shihui, Dai Shuai, Liu Hongtao
2019, 10(5): 584-588. doi: 10.3969/j.issn.1674-7445.2019.05.019
Abstract(191) HTML (182) PDF 1554KB($!{article.pdfDownCount})
Abstract:
  Objective  To investigate the management and clinical effect of accessory renal artery in living-related donor renal transplantation.  Methods  Clinical data of 277 donors and recipients undergoing living-related donor renal transplantation were retrospectively analyzed. According to the results of preoperative CT angiography (CTA), the donor kidney was selected and the accessory renal artery of the renal graft was treated intraoperatively. Intraoperative status of the donors, and intraoperative management, postoperative complications, clinical prognosis of the recipients were summarized.  Results  Among 277 cases of renal transplantation, accessory renal arteries were detected in 83 donors by preoperative CTA examination with an accuracy rate of 95%. Fifty-eight donor kidneys with accessory renal arteries were obtained. Twenty-five donor kidneys with accessory renal arteries were reconstructed and anastomized by vascular repairing. Among them, 1 patient presented with anastomotic thrombosis during abdominal closure, whereas the other 24 cases were successfully anastomized with excellent blood flow. No complications, such as hemorrhage, renal graft embolism, ureteral necrosis and urinary fistula, occurred after renal transplantation. The 1-year survival rates of the recipients and renal grafts were 94% and 91%. The clinical efficacy did not significantly differ between the recipients with single renal artery and their counterparts with accessory renal artery (P > 0.05).  Conclusions  It can be obtained good clinical efficacy of renal transplantation by selecting a suitable donor kidney and reconstructing and anastomizing the accessory renal artery of the renal graft through vascular repair.
Experience summary of complex hepatic artery reconstruction in orthotopic liver transplantation
Ye Zhenghui, Zhao Hongchuan, Geng Xiaoping, Huang Fan, Wang Guobin, Yu Xiaojun, Wu Ruolin, Hou Liujin
2019, 10(5): 589-593, 611. doi: 10.3969/j.issn.1674-7445.2019.05.020
Abstract(149) HTML (20) PDF 990KB($!{article.pdfDownCount})
Abstract:
  Objective  To summarize the experience of complex hepatic artery reconstruction in orthotopic liver transplantation.  Methods  Clinical data of 7 liver transplantation recipients who underwent complex hepatic artery reconstruction from January 2015 to March 2019 were retrospectively analyzed. Among them, 4 recipients received classical liver transplantation and 3 cases underwent piggyback liver transplantation. Intraoperative general conditions including anhepatic phase, intraoperative blood loss, hepatic artery anastomosis time and operation time of the recipients were recorded. The clinical prognosis and complications were observed.  Results  In two donors, variant right hepatic artery was used for vascular reconstruction. The celiac trunk or the common hepatic artery of the donors was anastomosed with the common hepatic artery of the recipients. Iliac artery bypass was employed in 2 cases, and then the hepatic artery of the donors was anastomosed with the abdominal aorta of the recipients. The superior mesenteric artery of 1 donor was end-to-end anastomosed with the common hepatic artery of the recipient. The celiac trunk of 1 donor was anastomosed with the splenic artery of the recipient. Only 1 case was required to undergo secondary liver transplantation due to acute hepatic artery thrombosis after hepatic artery anastomosis. All the 6 recipients successfully completed the liver transplantation. No perioperative death was observed. The anhepatic phase endured from 49 to 77 min. The intraoperative blood loss was ranged from 300 to 1 500 mL. The anastomosis time of hepatic artery was 23-56 min. The operation time was ranged from 5.3 to 11.1 h. The length of postoperative hospital stay was 23-56 d. Neither hepatic artery thrombosis nor stenosis occurred. The liver function of all recipients was basically restored to normal within postoperative 2 weeks. No severe surgical complications occurred. The liver graft achieved excellent function.  Conclusions  Appropriate identification of the hepatic artery variation, proper management of liver artery of the donors and recipients and reconstructing the blood supply of liver graft are the crucial procedures of liver transplantation.
Clinical application of ECMO in protecting donor liver in organ donation after citizen's death
Ding Limin, Li Xinchang, Xu Zhidan, Yang Xiaogang, Huang Xiaomei, Luo Wenfeng
2019, 10(5): 594-598. doi: 10.3969/j.issn.1674-7445.2019.05.021
Abstract(347) HTML (126) PDF 877KB($!{article.pdfDownCount})
Abstract:
  Objective  To explore the feasibility of extracorporeal membrane oxygenation (ECMO) in protecting the donor liver in donation after citizen's death.  Methods  Clinical data of 16 donors and recipients undergoing liver transplantation using ECMO to protect the donor liver were retrospectively analyzed. The effect of ECMO on different indicators of the donors was evaluated. The liver function and clinical prognosis of the recipients after liver transplantation were observed.  Results  Compared with the time before ECMO, the heart rate, total bilirubin (TB), alanine transaminase (ALT) and aspartate transaminase (AST) of the donors after ECMO were significantly reduced, whereas the systolic blood pressure, diastolic blood pressure and partial pressure of arterial oxygen (PaO2) were remarkably increased (all P < 0.05). The liver function of the recipients was properly recovered after liver transplantation, and gradually restored normal at postoperative 7 to 28 d. Postoperative complications occurred in 3 recipients, including delayed liver function recovery in 1 case, biliary tract stenosis in 1 case and portal vein thrombosis in 1 case. Among them, the patient with portal vein thrombosis died after secondary operation, and the other 2 patients were recovered and discharged after symptomatic treatment.  Conclusions  The hemodynamics, liver function and other indicators of donors from donation after citizen's death are significantly improved after ECMO, and the liver function of the recipients also recover well.
Review Articles
Research progress on cardiac xenotransplantation
Jiang Xingpei, Tian Hai, Sun Lu, Guo Ruilin, Liu Kaiyu, Jiang Shulin
2019, 10(5): 599-602. doi: 10.3969/j.issn.1674-7445.2019.05.022
Abstract(202) HTML (104) PDF 665KB($!{article.pdfDownCount})
Abstract:
Research progress in the effect of immunosuppressive agents on liver fibrosis after renal transplantation
Ding Peng, Li Hao, Zhuang Quan, Ming Yingzi
2019, 10(5): 603-607. doi: 10.3969/j.issn.1674-7445.2019.05.023
Abstract(257) HTML (108) PDF 1062KB($!{article.pdfDownCount})
Abstract:
Mechanism of extracorporeal photochemotherapy in inhibiting immune rejection in organ transplantation
Wei Yuxiaug, Shi Bingyi
2019, 10(5): 608-611. doi: 10.3969/j.issn.1674-7445.2019.05.024
Abstract(195) HTML (109) PDF 785KB($!{article.pdfDownCount})
Abstract:
Research progress on immunosuppressive effect and mechanism of mesenchymal stem cells in organ transplantation
Zhang Liyi, Tong Calling, An Ke, Zhong Jiaying, Yu Shengnan, Lin Qingru, Ma Yunhan, Chen Yingyu, Xia Junjie, Qi Zhongquan
2019, 10(5): 612-616. doi: 10.3969/j.issn.1674-7445.2019.05.025
Abstract(145) HTML (139) PDF 843KB($!{article.pdfDownCount})
Abstract: